Product NDC: | 55154-4518 |
Proprietary Name: | AVANDIA |
Non Proprietary Name: | rosiglitazone maleate |
Active Ingredient(s): | 8 mg/1 & nbsp; rosiglitazone maleate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55154-4518 |
Labeler Name: | Cardinal Health |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021071 |
Marketing Category: | NDA |
Start Marketing Date: | 19990528 |
Package NDC: | 55154-4518-4 |
Package Description: | 30 POUCH in 1 CARTON (55154-4518-4) > 1 TABLET, FILM COATED in 1 POUCH (55154-4518-6) |
NDC Code | 55154-4518-4 |
Proprietary Name | AVANDIA |
Package Description | 30 POUCH in 1 CARTON (55154-4518-4) > 1 TABLET, FILM COATED in 1 POUCH (55154-4518-6) |
Product NDC | 55154-4518 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | rosiglitazone maleate |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 19990528 |
Marketing Category Name | NDA |
Labeler Name | Cardinal Health |
Substance Name | ROSIGLITAZONE MALEATE |
Strength Number | 8 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Peroxisome Proliferator Receptor gamma Agonist [EPC],Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR gamma [Chemical/Ingredient],Thiazolidinedione [EPC],Thiazolidinediones [Chemical/Ingredient] |